AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 251 min read$EXPE

Dzielak Robert J sold $336K of EXPE

Dzielak Robert J (Chief Legal Officer & Sec'y) sold 1,004 shares of Expedia Group, Inc. (EXPE) at $335.00 ($0.34M total) on 2026-08-24.

Original reporting
SEC EDGAR · Dzielak Robert J
Published Aug 25, 2026, 8:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 8:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$EXPE
Neutral
medium confidence
Mentioned
$EXPE
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EXPENeutralLow
01

Why it matters

The sale represents a routine reduction in holdings; unlikely to affect stock valuation materially.

02

Market read

Minor insider transaction with limited trading relevance.

03

What to watch

Potential upcoming legal matters not disclosed; sale may be routine diversification.

Relevance 4/10Novelty 4/10Timing: filing date 2026-08-25

Background

Form 4 filings disclose insider transactions; investors monitor for material changes in insider holdings.

Company-level read

Ticker impact

$EXPENeutralMedium confidence
Context

Chief Legal Officer sold 1,004 shares for $336,340, reducing his stake to 104,331 shares.

Expected impact

No significant move; possible slight downward pressure.

Evidence & confidence

Sale size is modest relative to market cap and typical insider activity.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Insider sell could signal concerns, but size is too small to infer material risk.

Key entities

  • Person
    Robert J. Dzielak

    Chief Legal Officer & Secretary of Expedia Group, Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

EXPE insider trading history →

Related articles

SEP 24
$ABNBMed

Airbnb Slides to $150 as Wall Street Fears AI Will Skip the Middleman

Airbnb (ABNB) fell 8% to $150 despite 17% revenue growth, as investors reacted to Meta's AI agent Muse, which could bypass travel intermediaries. Booking Holdings (BKNG) and Expedia (EXPE) also dropped. Airbnb's unique inventory and direct host-guest relationships may mitigate AI impact. The stock's consensus target is $184.35.

aol.com3 min
SEP 24
$METAMed

Meta’s Muse Drags Down Stocks That Depend on ‘Consumer Inertia’

Shares of banks, insurers, and travel agencies fell as investors worry about Meta's AI agent, Muse, disrupting industries reliant on consumer inertia. Meta's stock rose 11% on Monday. Affected companies include JPMorgan, Morgan Stanley, Allstate, Charles Schwab, Expedia, and Booking Holdings. Goldman Sachs identifies telecoms, insurance, and utilities as sectors at risk.

yahoo.com2 min
SEP 22
$EXPEMed

Morgan Stanley Cuts Expedia (EXPE) to Underweight as Rivals Pull Ahead on Users

Morgan Stanley downgraded Expedia (EXPE) to Underweight with a $235 price target, citing flat user growth compared to rivals like Booking.com and Airbnb. The analyst noted Expedia's higher marketing costs and exposure to AI-driven search tools. Despite this, Expedia's B2B segment grew 21% in Q2, and the company raised its full-year revenue and margin outlook. The stock has fallen since the downgrade.

insidermonkey.com2 min
SEP 17
$EXPEMed

Wall Street Warning Sends Expedia Shares Sliding

Expedia (EXPE) shares fell after Morgan Stanley initiated coverage with an Underweight rating, citing stagnant user growth and competition. The firm set a $235 price target, despite recent earnings and a smaller upgrade from TD Cowen. Expedia's growth outlook and cash generation remain strong, but debt and slowing revenue growth pose risks.

tipranks.com2 min
SEP 16
$EXPEMedAI 8/10

Expedia Stock Is Up Almost 6% This Week. Here’s What’s Behind the Move

Expedia Group (EXPE) stock rose nearly 6% this week after reporting strong Q2 results, beating earnings and revenue estimates for the fifth consecutive quarter. The company raised full-year guidance, citing broad-based growth, particularly in U.S. consumer demand and B2B segment. However, Morgan Stanley initiated coverage with an Underweight rating and a $235 price target, citing concerns about inventory and direct traffic. Expedia's CEO highlighted the company's consistent performance, and a va

tikr.com2 min